How many unapproved ingredients ended up in our food and what the FDA can do about it
Around 1,000 ingredients found in grocery store foods have never undergone safety checks by the Food and Drug Administration (FDA). This has raised significant safety concerns among experts. So, how did the FDA allow this to happen? The answer seems to stem from a somewhat flexible understanding of lesser-known regulatory bodies. Companies can often decide […]
FDA Commissioner Dedicated to Reviewing Abortion Pill
FDA Commissioner Reviews Mifepristone Safety On Monday, FDA Commissioner Marty McCurry announced a commitment to review the safety of Mifepristone, the first medication in a two-drug abortion regimen. This decision came in response to a letter from Senator Josh Hawley (R-MO), who raised concerns following a new study indicating potential complications associated with the drug. […]
FDA head promises to look into mifepristone
The Director of the Food and Drug Administration, Marty McCurry, expressed his intention to review the abortion medication Mifepristone in correspondence with Senator Josh Hawley (R-Mo.). “As with all medications, the FDA is continuously monitoring safety data from Mifepristone for medical termination in early pregnancy,” McCurry noted. He emphasized his commitment to engaging with professional […]
AI tool for breast cancer receives FDA approval, utilizes mammograms to assess risk
The FDA Allows AI Tools to Predict Breast Cancer Risk The U.S. Food and Drug Administration (FDA) has given the green light to an artificial intelligence (AI) tool designed to estimate the risk of breast cancer. This approval is a significant step toward enhancing early detection methods. Clairity, the tech company behind Clarity Breast, has […]
FDA grants limited approval for new Moderna COVID vaccine
Moderna’s New COVID-19 Vaccine Approved by FDA The FDA has given the green light to Moderna’s latest COVID-19 vaccine, known as Mnexspike. This new option is specifically aimed at adults aged 65 and older, along with younger individuals, ages 12 to 64, who have at least one underlying medical condition that puts them at higher […]
FDA notice advises of uncommon but serious itching after stopping allergy medications
Some individuals may face a serious reaction when discontinuing two popular allergy medications. The U.S. Food and Drug Administration (FDA) has issued a warning regarding cetirizine (Zyrtec) and levocetirizine (Xyzal), indicating that those who cease their long-term use could experience “rare but severe itching,” a condition known as Pruritus. This itching has been reported by […]
FDA issues alert about uncommon but serious itching following the use of popular allergy drugs
Hundreds of individuals who have discontinued using allergy medications like Zyrtec and Xyzal have reported experiencing new and uncomfortable side effects, according to a recent warning from the US Food and Drug Administration. The warning highlights that in “rare but severe” instances, those who stop taking these drugs experience intense itching, prompting them to seek […]
FDA intends to restrict who can get the COVID vaccine
Covid Vaccine Approval Limited to High-Risk Groups The Trump administration announced on Tuesday that it intends to restrict access to the updated Covid-19 vaccine primarily to adults aged 65 and older and those considered at high risk for severe illness from the virus. This decision has sparked discussions about what it might mean for healthier […]
FDA plans to withdraw COVID-19 vaccine guidance for children and healthy adults
FDA to Change COVID-19 Vaccine Approval Process The U.S. Food and Drug Administration (FDA) has decided to halt the automatic approval of COVID-19 vaccines for low-risk groups, which includes both children and healthy adults. This shift seems to be aimed at ensuring that only those who are considered healthy by their healthcare providers will automatically […]
FDA revamps COVID vaccine approval process to prioritize older adults and high-risk groups
FDA Updates COVID-19 Vaccine Approval Standards The Food and Drug Administration (FDA) is revising its annual COVID-19 vaccine approval process to hold vaccines for low-risk individuals to a higher standard of evidence. The focus will be on “high-risk” groups, particularly those aged 65 and older. According to Vinay Prasad, the FDA’s head of biological assessment […]